We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to define your participant criteria, find participants for research and handle incentives.
First published during the 2022 to 2024 Sunak Conservative government
First published during the 2019 to 2022 Johnson Conservative government
The government responds to the ACMD's report on recently encountered novel benzodiazepines and related compounds.
Results of our survey of registered providers to review how they are coping with the impact of COVID-19.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).